NTRK Gene Fusions: Novel Targets for Tumor-Agnostic Cancer Therapy
Advanced sequencing techniques have revolutionized the understanding of how cancer has developed and enabled treatment selection based on genomic characterization of the tumor.
Source: OncLive
XPeng (NYSE: XPEV) Unveils Beta Version Navigation Guided Pilot Function




